The global nasometry devices market is estimated to be valued at US$ 336.9 Mn in 2024 and is expected to exhibit a CAGR of 4.3% over the forecast period 2024 to 2031. Nasometry devices are used to accurately measure nasalance scores of patients to assess oral-nasal function in speech. These devices help optimize treatment options by measuring the relative amounts of nasal and oral resonance during speech.
The Global Nasometry devices Market Demand are usually portable devices that detect sounds and vibrations traveling through the nose and mouth. They provide objective and reliable nasalance scores which help clinicians diagnose issues related to cleft palate, velopharyngeal dysfunction, nasal obstruction and other speech disorders. The data obtained can help determine the need for surgical intervention or therapies like speech therapy. The demand for nasometry devices is growing owing to the rising prevalence of speech disorders requiring accurate respiratory assessment.
Key Takeaways
Key players operating in the nasometry devices market are GM Instruments Ltd., Rose Medical Solutions Ltd., PENTAX Medical, Otopront GmbH, BioRESEARCH Associates, Inc., Medtronic, Homoth Medizinelektronik, Recorders & Medicare Systems Private Limited, Atmos MedizinTechnik GmbH & Co.KG, Collin Medical, Euroclinic MediCare Solutions, SWORD MEDICAL LTD., Glottal Enterprises Incorporated, and Vivos Therapeutics Inc.
The global nasometry devices market is driven by the growing prevalence of speech disorders worldwide. Nasalance scores provided by nasometry devices help in better diagnosis and management of conditions involving nasal obstruction or oral-nasal dysfunction. This is expected to fuel the demand for nasometry devices over the forecast period.
Major players in the nasometry devices market are focusing on expansion in emerging markets to capitalize on high growth opportunities. Favorable government initiatives and improvement in access to healthcare services in developing nations is supporting the adoption of advanced diagnostic technologies. This is expected to boost the nasometry devices market globally.
Market Key Trends
The increasing adoption of telehealth and remote monitoring is one of the key trends in the nasometry devices market. The ongoing COVID-19 pandemic accelerated the use of digital health technologies. Nasometry devices with wireless connectivity features allow clinicians to remotely monitor patients and assist in diagnosis without requiring in-person visits. This makes treatment more accessible and convenient. Leading manufacturers are focusing on integrating smartphones and software applications with nasometry devices to enable telehealth capabilities. This trend is expected to have a positive impact on the nasometry devices market growth over the forecast period.
Porter’s Analysis
Threat of new entrants: Low costs associated with setting up nasometry devices manufacturing units.
Bargaining power of buyers: Nasometry devices have limited options available, giving buyers less negotiating power.
Bargaining power of suppliers: Key components used in manufacturing nasometry devices such as sensors and software have few alternative suppliers.
Threat of new substitutes: Other diagnostic methods can substitute nasometry but each have their limitations.
Competitive rivalry: Intense as major players compete on quality, features and pricing.
Geographical Regions
North America region accounted for the largest share of the global nasometry devices market in terms of value in 2024, owing to increasing usage of nasal endoscopy and strong presence of key players in the US.
Asia Pacific region is expected to witness the fastest growth during the forecast period, attributed to rising healthcare expenditures, growing population and increasing burden of respiratory disorders in countries like China and India.
Geographical Regions
Europe region held a significant share of the global nasometry devices market in 2024 and is expected to maintain its dominance during the forecast period. This is attributed to growing adoption of minimally invasive diagnostic procedures and rising research funding for respiratory diseases in countries like Germany, UK and France.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it